Glenmede Trust CO Na Neurocrine Biosciences Inc Transaction History
Glenmede Trust CO Na
- $20.6 Billion
- Q3 2024
A detailed history of Glenmede Trust CO Na transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Glenmede Trust CO Na holds 10,261 shares of NBIX stock, worth $1.41 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,261
Previous 11,089
7.47%
Holding current value
$1.41 Million
Previous $1.53 Million
22.61%
% of portfolio
0.01%
Previous 0.01%
Shares
25 transactions
Others Institutions Holding NBIX
# of Institutions
626Shares Held
94MCall Options Held
632KPut Options Held
621K-
Black Rock Inc. New York, NY14.2MShares$1.94 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$1.37 Billion0.02% of portfolio
-
State Street Corp Boston, MA5.15MShares$706 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.57MShares$353 Million0.47% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.86MShares$255 Million3.62% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $13.1B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...